top of page
Homepage

Advancing Healthcare 
Through Innovation

Clinical Safety First

We prioritise patient safety by introducing specialised technologies for anaesthesia, ensuring that practitioners have the most reliable tools for critical care environments.

Malignant Hyperthermia

Providing rapid-response solutions and essential products for the management of Malignant Hyperthermia, helping hospitals maintain the highest standards of readiness and care.

est. 2014

The Ryanomed Vision

A dedicated partner in modernising anaesthesia-related care.

Ryanomed identifies and imports advanced medical technologies to meet evolving clinical needs. We focus on bridging the gap between innovation and implementation.

Our Approach

We provide end-to-end solutions for healthcare facilities, ensuring seamless integration of new technologies into surgical workflows.

Product Identification

We source high-performance medical products globally, focusing on specialised niches like anaesthesia and critical care to ensure your facility has access to the best technology.

Strategic Importing

Our team handles the complex logistics of medical device importation, ensuring all regulatory requirements are met for a reliable supply chain of essential healthcare equipment.

Clinical Integration

We provide the technical knowledge through Key Opinion Leaders and clinical support necessary for anaesthetists to adopt new tools confidently, maximising the efficacy of every product we introduce.

Evolving Solutions

By constantly monitoring healthcare trends, we adapt our portfolio to meet the shifting demands of modern medicine, keeping your procurement department ahead of the curve.

Clinical Impact

100%

Quality Focus

High

Innovation

24

Hour Clinical
Availability

01

Goal: Patient Safety

Focus Areas

Safety

Specialised focus on preventing and managing anaesthetic crises, offering products that meet the rigorous demands of operating rooms and emergency medical services worldwide.

Innovation

Introducing breakthrough technologies that refine traditional anaesthesia practices, enhancing precision and improving patient monitoring throughout the surgical process.

Procurement

Streamlining the acquisition of high-stakes medical supplies for hospital systems, ensuring cost-effectiveness without compromising on the quality of clinical outcomes.

Our Products

Solutions for Malignant Hyperthermia preparedness

Packshot photography of two yellow, branded funnel-shaped plastic tools. The objects are presented clearly against a clean white background.

01

VAPOR-CLEAN™ Activated Charcoal Filters for Malignant Hyperthermia Preparedness

Rapid anaesthesia machine preparation. Reduced volatile anaesthetic exposure. Greater preparedness for MH-susceptible patients. 

Rapid Preparation. Reliable Filtration.

Modern anaesthesia workstations can retain volatile anaesthetic agents within their internal components, even after the anaesthetic has been discontinued. These residual vapours may subsequently be released into the breathing circuit, potentially exposing patients susceptible to malignant hyperthermia (MH) to triggering agents. Traditional machine preparation relies on prolonged high-flow flushing to reduce residual anaesthetic concentrations. Depending on the workstation, this process can take considerably longer than an hour. Vapor-Clean™ activated charcoal filters offer an alternative approach, significantly reducing preparation time while helping to minimise patient exposure to residual volatile anaesthetic agents. Following the recommended 90-second high-flow flush and installation of the filters, concentrations of isoflurane, sevoflurane and desflurane can be reduced to below 5 parts per million (ppm) in less than two minutes. The filters maintain these concentrations below 5 ppm for up to 12 hours of continuous use, subject to the manufacturer’s operating instructions.

How Does the Technology Work?

Vapor-Clean™ uses activated charcoal to adsorb residual volatile anaesthetic agents from the gas passing through the breathing circuit. A filter is positioned on each of the anaesthesia machine’s inspiratory and expiratory ports. Together, they help prevent residual volatile anaesthetic vapours from reaching the patient. Unlike conventional flushing methods, which can be affected by the release of previously absorbed anaesthetic agents from internal machine components (the rebound phenomenon), activated charcoal filters continue to capture residual vapours throughout the procedure.

An Alternative to Prolonged Machine Flushing

Preparing modern anaesthesia workstations for MH-susceptible patients can be time-consuming. Published studies have demonstrated that conventional flushing requirements vary considerably between machine models, with some requiring more than 60 minutes of preparation. Activated charcoal filtration provides a practical alternative, reducing the time required to prepare an anaesthesia workstation without relying on prolonged machine-specific flushing procedures. This can be particularly valuable when MH susceptibility is identified unexpectedly, helping reduce unnecessary operating theatre delays.

Key Features and Benefits

  • Rapid preparation: Achieve the recommended filter-based preparation in less than two minutes, including the initial 90-second high-flow flush.
  • Broad-spectrum volatile anaesthetic filtration: Removes residual isoflurane, sevoflurane and desflurane.
  • Extended filtration: Maintains volatile anaesthetic concentrations below 5 ppm for up to 12 hours of continuous use.
  • Reduced rebound exposure: Continues adsorbing residual anaesthetic vapours throughout the procedure.
  • Reduced preparation time: Minimises reliance on lengthy, conventional machine-flushing procedures.
  • Low flow resistance: Designed to minimise additional resistance within the breathing circuit.
  • Flexible application: Connects to the inspiratory and expiratory ports of the anaesthesia workstation.

An Additional Tool During an MH Crisis

When malignant hyperthermia is suspected during general anaesthesia, immediate discontinuation of triggering volatile anaesthetic agents and prompt administration of dantrolene are critical. Vapor-Clean™ filters can be incorporated into the anaesthesia breathing circuit to help reduce further exposure to residual volatile anaesthetic agents while allowing mechanical ventilation to continue. This provides an additional means of managing the anaesthesia delivery system without necessarily having to replace the entire workstation. Importantly, filter placement must never delay dantrolene administration or other essential MH treatment.

Supporting Safer Anaesthesia Practice

Preparedness for malignant hyperthermia requires appropriate equipment, established protocols and rapid access to effective treatment. Vapor-Clean™ activated charcoal filters provide an additional practical solution for anaesthesia teams, helping simplify workstation preparation and reduce exposure to residual triggering agents in patients susceptible to MH.

02

MH Crash Cart

MHCSA recommends that “every facility administering MH-triggering agents must be prepared for an MH emergency, with an accessible, regularly checked emergency dantrolene supply and a clearly established crisis protocol.”

A mobile, purpose-designed MH emergency trolley for hospitals and day clinics.

Includes:

  • Colour-coded, step-by-step crisis management guides.
  • QR-linked dantrolene dosage calculator.
  • Anaesthetic machine preparation charts and activated charcoal filters.
  • Larach Clinical Grading Scale.
  • Organised, labelled emergency medication drawers.
  • Refill checklist and sign-off booklet.
  • Ready for rapid deployment to any theatre.
Studio photography of a bright red medical crash cart. It features labeled drawers with clinical equipment and is set against a clean, neutral background.

Global Partner Network

Affiliation

bottom of page